SCHEMBL21587437

SCHEMBL21587437

Cc1cccc(C(O)CNCCCCCCOCCOCc2c(Cl)cccc2Cl)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRB2 P07550 19/20 0.69
▸ ADRB1 P08588 15/20 0.69
▸ SLC6A2 P23975 2/20 0.69
▸ HTR2A P28223 2/20 0.69
▸ SLC6A4 P31645 2/20 0.69
▸ ADRA1A P35348 2/20 0.69
▸ SLC6A3 Q01959 2/20 0.69
▸ MLNR O43193 1/20 0.69
▸ NR1I2 O75469 1/20 0.69
▸ ABCB11 O95342 1/20 0.69
▸ ADORA3 P0DMS8 1/20 0.69
▸ DRD1 P21728 1/20 0.69
▸ PTGS2 P35354 1/20 0.69
▸ MC3R P41968 1/20 0.69
▸ PDE4D Q08499 1/20 0.69
▸ SCN5A Q14524 1/20 0.69
▸ GHSR Q92847 1/20 0.69
▸ ADRB3 P13945 14/20 0.65
▸ OPRK1 P41145 2/20 0.48
▸ KDM4E B2RXH2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21587434 0.89 ADRB2 (0.56) ADRB2ADRB1SLC6A2HTR2ASLC6A4
SCHEMBL21024234 0.87 ADRB2 (0.77) ADRB2ADRB1SLC6A2HTR2ASLC6A4
SCHEMBL26262583 0.85 ADRB2 (0.66) ADRB2ADRB1SLC6A2HTR2ASLC6A4
SCHEMBL17031690 0.85 ADRB2 (0.72) ADRB2ADRB1SLC6A2HTR2ASLC6A4
SCHEMBL3982300 0.84 ADRB2 (0.67) ADRB2ADRB1SLC6A2HTR2ASLC6A4
SCHEMBL17031688 0.83 ADRB2 (0.84) ADRB2ADRB1SLC6A2HTR2ASLC6A4
SCHEMBL12039344 0.83 ADRB2 (0.75) ADRB2ADRB1SLC6A2HTR2ASLC6A4
SCHEMBL3979584 0.82 ADRB2 (0.77) ADRB2ADRB1SLC6A2HTR2ASLC6A4
SCHEMBL928189 0.82 ADRB2 (1.00) ADRB2ADRB1SLC6A2HTR2ASLC6A4
Vilanterol SCHEMBL142630 0.82 ADRB2 (1.00) ADRB2ADRB1SLC6A2HTR2ASLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3578169-A1 PHARMACEUTICAL FORMULATIONS COMPRISING 4-{(1 R)-2-[(6-{2-[(2,6-DICHLOROBENZYL)OXY]ETHOXY}HEXYL)AMINO]-1-HYDROXYETHYL}-2-(HYDROXYMETHYL)PHENOL GLAXO GROUP LIMITED (GB) 2019-12-11 — — EP disclosed
Send feedback